1. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2016; :. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  2. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  3. Rodchuae, M, Ruangpin, C, Katchamart, W. Clinical manifestations, treatment outcomes, and risk factors for sternoclavicular septic arthritis. Rheumatol. Int. 2017;37 (5):819-824. doi: 10.1007/s00296-017-3673-x. PubMed PMID:28239769 .
  4. Teerawattananon, C, Tantayakom, P, Suwanawiboon, B, Katchamart, W. Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: A systematic review and meta-analysis. Semin. Arthritis Rheum. 2017;46 (4):520-528. doi: 10.1016/j.semarthrit.2016.07.008. PubMed PMID:27569276 .
  5. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  6. Chiowchanwisawakit, P, Wattanamongkolsil, L, Srinonprasert, V, Petcharat, C, Siriwanarangsun, P, Katchamart, W et al.. Developing the Thai Siriraj Psoriatic Arthritis Screening Tool and validating the Thai Psoriasis Epidemiology Screening Tool and the Early Arthritis for Psoriatic Patients questionnaire. Rheumatol. Int. 2016;36 (10):1459-68. doi: 10.1007/s00296-016-3513-4. PubMed PMID:27333800 .
  7. Tantayakom, P, Koolvisoot, A, Arromdee, E, Chiowchanwisawakit, P, Muangchan, C, Katchamart, W et al.. Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis. Joint Bone Spine. 2016;83 (5):563-7. doi: 10.1016/j.jbspin.2015.10.016. PubMed PMID:27238198 .
  8. Katchamart, W, Koolvisoot, A, Aromdee, E, Chiowchanwesawakit, P, Muengchan, C. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol. Int. 2015;35 (10):1693-9. doi: 10.1007/s00296-015-3271-8. PubMed PMID:25903353 .
  9. Buppajamrntham, T, Palavutitotai, N, Katchamart, W. Clinical manifestation, diagnosis, management, and treatment outcome of pericarditis in patients with systemic lupus erythematosus. J Med Assoc Thai. 2014;97 (12):1234-40. . PubMed PMID:25764628 .
  10. Palavutitotai, N, Buppajarntham, T, Katchamart, W. Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus. J Clin Rheumatol. 2014;20 (8):418-21. doi: 10.1097/RHU.0000000000000179. PubMed PMID:25417677 .
  11. Chaisurote, J, Khemajira, K, Wanwisa, C, Katchamart, W. Validation of the Thai version of the questionnaire for identifying subjects with potential rheumatic diseases. J Med Assoc Thai. 2014;97 (3):308-16. . PubMed PMID:25123010 .
  12. Lee, EB, Fleischmann, R, Hall, S, Wilkinson, B, Bradley, JD, Gruben, D et al.. Tofacitinib versus methotrexate in rheumatoid arthritis. N. Engl. J. Med. 2014;370 (25):2377-86. doi: 10.1056/NEJMoa1310476. PubMed PMID:24941177 .
  13. Shea, B, Swinden, MV, Ghogomu, ET, Ortiz, Z, Katchamart, W, Rader, T et al.. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J. Rheumatol. 2014;41 (6):1049-60. doi: 10.3899/jrheum.130738. PubMed PMID:24737913 .
  14. Katchamart, W, Benjamanukul, S, Chiowchanwesawakit, P. Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis. Int J Rheum Dis. 2014;17 (2):181-5. doi: 10.1111/1756-185X.12215. PubMed PMID:24618364 .
  15. Rojanasantikul, P, Pattrapornpisut, P, Anuruckparadorn, K, Katchamart, W. The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis. Clin. Rheumatol. 2014;33 (7):919-23. doi: 10.1007/s10067-014-2544-z. PubMed PMID:24577818 .
  16. Shea, B, Swinden, MV, Tanjong Ghogomu, E, Ortiz, Z, Katchamart, W, Rader, T et al.. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2013; (5):CD000951. doi: 10.1002/14651858.CD000951.pub2. PubMed PMID:23728635 .
  17. Chiowchanwisawakit, P, Taweesuk, A, Katchamart, W, Srinonprasert, V. Prevalence and risk factors of symptomatic hyperuricemia; quality of care of patients with hyperuricemia in a university hospital. J Med Assoc Thai. 2013;96 Suppl 2 :S178-86. . PubMed PMID:23590040 .
  18. Katchamart, W, Ussavasodhi, P, Chiowchanwesawakit, P, Chanapai, W. Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI). Rheumatol. Int. 2013;33 (10):2503-8. doi: 10.1007/s00296-013-2749-5. PubMed PMID:23588410 .
  19. Katchamart, W. Reply to the letter regarding "Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis". J. Gastroenterol. 2013;48 (5):675. doi: 10.1007/s00535-013-0786-1. PubMed PMID:23494647 .
  20. Chiowchanwisawakit, P, Nilganuwong, S, Srinonprasert, V, Boonprasert, R, Chandranipapongse, W, Chatsiricharoenkul, S et al.. Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy. Int J Rheum Dis. 2013;16 (1):47-55. doi: 10.1111/1756-185X.12029. PubMed PMID:23441772 .
  21. Chadchavalpanichaya, N, Katchamart, W, Charatrungolan, T, Nualnim, P. The efficacy of adjustable toe splint on decreasing metatarsalgia in patients with lesser toe deformity: a prospective, randomized single-blinded controlled trial. J Med Assoc Thai. 2012;95 (12):1575-82. . PubMed PMID:23390790 .
  22. Jarupongprapa, S, Ussavasodhi, P, Katchamart, W. Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis. J. Gastroenterol. 2013;48 (7):830-8. doi: 10.1007/s00535-012-0717-6. PubMed PMID:23208017 .
  23. Chiowchanwisawakit, P, Srinonprasert, V, Nilganuwong, S, Katchamart, W, Koolvisoot, A, Arromdee, E et al.. Antimalarial-induced maculopathy: accuracy of Amsler grid as a diagnostic tool and risk factors. J Med Assoc Thai. 2012;95 Suppl 2 :S218-26. . PubMed PMID:22574553 .
  24. Salliot, C, Finckh, A, Katchamart, W, Lu, Y, Sun, Y, Bombardier, C et al.. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Ann. Rheum. Dis. 2011;70 (2):266-71. doi: 10.1136/ard.2010.132134. PubMed PMID:21097801 .
  25. Katchamart, W, Faulkner, A, Feldman, B, Tomlinson, G, Bombardier, C. PubMed had a higher sensitivity than Ovid-MEDLINE in the search for systematic reviews. J Clin Epidemiol. 2011;64 (7):805-7. doi: 10.1016/j.jclinepi.2010.06.004. PubMed PMID:20926257 .
  26. Machado, P, Castrejon, I, Katchamart, W, Koevoets, R, Kuriya, B, Schoels, M et al.. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann. Rheum. Dis. 2011;70 (1):15-24. doi: 10.1136/ard.2010.130625. PubMed PMID:20724311 PubMed Central PMC3002765.
  27. Katchamart, W, Bourré-Tessier, J, Donka, T, Drouin, J, Rohekar, G, Bykerk, VP et al.. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. J. Rheumatol. 2010;37 (7):1422-30. doi: 10.3899/jrheum.090978. PubMed PMID:20516029 .
  28. Katchamart, W, Bombardier, C. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis. J. Rheumatol. 2010;37 (7):1411-5. doi: 10.3899/jrheum.090980. PubMed PMID:20436069 .
  29. Katchamart, W, Trudeau, J, Phumethum, V, Bombardier, C. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. Cochrane Database Syst Rev. 2010; (4):CD008495. doi: 10.1002/14651858.CD008495. PubMed PMID:20393970 .
  30. Katchamart, W, Johnson, S, Lin, HJ, Phumethum, V, Salliot, C, Bombardier, C et al.. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res (Hoboken). 2010;62 (8):1128-43. doi: 10.1002/acr.20188. PubMed PMID:20235210 .
  31. Katchamart, W, Trudeau, J, Phumethum, V, Bombardier, C. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 2009;68 (7):1105-12. doi: 10.1136/ard.2008.099861. PubMed PMID:19054823 PubMed Central PMC2689526.
  32. Visser, K, Katchamart, W, Loza, E, Martinez-Lopez, JA, Salliot, C, Trudeau, J et al.. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann. Rheum. Dis. 2009;68 (7):1086-93. doi: 10.1136/ard.2008.094474. PubMed PMID:19033291 PubMed Central PMC2689523.
Search PubMed